HIMS logo

HIMS

Hims & Hers Health Inc. Class A

$27.91
-$1.48(-5.04%)
46
Overall
20
Value
60
Tech
60
Quality
How is this score calculated?
Market Cap
$9.60B
Volume
21.68M
52W Range
$13.74 - $70.43
Target Price
$26.79

Company Overview

Mkt Cap$9.60BPrice$27.91
Volume21.68MChange-5.04%
P/E Ratio76.2Open$28.57
Revenue$1.5BPrev Close$29.39
Net Income$126.0M52W Range$13.74 - $70.43
Div YieldN/ATarget$26.79
Overall46Value20
Quality60Technical60

No chart data available

About Hims & Hers Health Inc. Class A

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector: Healthcare
Industry: Offices of Physicians, Mental Health Specialists

Latest News

Freeport, Southwest, Hims & Hers Trending Among Analysts

Analysts are intrested in these 5 stocks: ( ($FCX) ), ( ($LUV) ) and ( ($HIMS) ). Here is a breakdown of their recent ratings and the rationale beh...

TipRanks Weekend Auto-Generated Newsdesk4 days ago

Now Is the Time to Buy Hims & Hers Stock (HIMS), Says JPMorgan Chase

Joel Baglole4 days ago

Eli Lilly (LLY) Expands Partnership with Hims & Hers

Joel Baglole5 days ago

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Greenwich LifeSciences (GLSI) and Harmony Biosciences Holdings (HRMY)

Catie Powers7 days ago

Hims & Hers Stock Boosts on FDA Peptide Review, Leerink Analyst Calls Move a “Clear Positive”

Radhika Saraogi12 days ago
ABCD
1SymbolPriceChangeVol
2HIMS$27.91-5.0%21.68M
3
4
5
6

Get Hims & Hers Health Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.